Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (5): 458-462.

Previous Articles     Next Articles

Progression of long chain non coding RNA in the regulation of drug resistance in colorectal cancer

  

  1. Department of Clinical Medicine， the First Clinical Medical College，Nanjing Medical University， Nanjing 210029， China
  • Received:2017-10-07 Revised:2018-01-20 Online:2018-05-31 Published:2018-06-07

PDF (PC)

345

Abstract: Colorectal cancer has the characteristics of high incidence and high mortality. Chemotherapy is one of the conventional treatment methods. The production of tumor resistance is the main reason for the failure of chemotherapy. Long chain non coding RNA （lncRNA） is involved in many physiological and pathological processes， and plays an important role in tumor proliferation， apoptosis， drug resistance and metastasis. Therefore， it is of practical significance to study the role of lncRNA in the drug resistance of colorectal cancer. In this review， we reviewed the progression of lncRNA in drug resistance mechanism of colorectal cancer at home and abroad.

Key words: Colorectal cancer, Long chain non coding RNA（lncRNA）, Chemoresistance

CLC Number: 

  • R735.3
[1] MENG Cunying, AN Tai, SHI Shengmei, ZHANG Chunli, LIU Yan, YUAN Donghong, MA Ying, LIU Pengfei.. Expression of DCLK1 and Bmi-1 in colorectal cancer and their clinical significance [J]. Chinese Clinical Oncology, 2018, 23(5): 419-423.
[2] ZHANG Dezhi, ZHANG Yu, ZHU Shaogong.. Effect of rs10013228 polymorphism of VEGFR2 gene on prognosis of patients with R0 resection of colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 424-428.
[3] WANG Shanshan, WANG Haiyan, WU Bin, ZHAO Lihong, LI Dong, XIE Yan. . Observation of apatinib mesylate treatment on colon cancer failed in multi-line chemotherapy [J]. Chinese Clinical Oncology, 2018, 23(5): 453-457.
[4] YAO Bo, LU Na.. The role of radiotherapy in the management of rectal cancer with synchronous metastases [J]. Chinese Clinical Oncology, 2018, 23(5): 463-466.
[5] . Ｐｒｏｇｒｅｓｓｉｏｎ ｏｆ ｍｏｎｏｃｏｌｏｎａｌ ａｎｔｉｂｏｄｉｅｓ ｆｏｒ ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ ｉｎ 2008 [J]. Chinese Clinical Oncology, 2009, 14(1): 1-.
Viewed
Full text
345
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 345

  From Others local
  Times 8 337
  Rate 2% 98%

Abstract
238
Just accepted Online first Issue
0 0 238
  From Others
  Times 238
  Rate 100%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
[1] . [J]. Chinese Clinical Oncology, 2009, 14(1): 96 .
[2] . [J]. Chinese Clinical Oncology, 2009, 14(1): 89 .
[3] . [J]. Chinese Clinical Oncology, 2009, 14(1): 80 .
[4] . [J]. Chinese Clinical Oncology, 2009, 14(1): 74 .
[5] . [J]. Chinese Clinical Oncology, 2009, 14(1): 47 .
[6] . [J]. Chinese Clinical Oncology, 2009, 14(1): 68 .
[7] ＸＵＷｅｉ-ｇｕｏ，ＹＡＮＧＸｉａｏ-ｑｉｎｇ，ＨＡＯＳｈｉ-ｚｈｕ，ＳＯＮＧＪｉ-ｎｉｎｇ，ＺＨＡＮＧＰｅｎｇ-ｄｏｎｇ，ＨＵＣｈａｎ-ｃｈａｎ，ＷＡＮＧＷｅｎ-ｙａ. Ｔｈｅｅｘｐｒｅｓｓｉｏｎｏｆｎｅｕｒｏｐｉｌｉｎ-１ａｎｄｉｔｓｃｏｒｒｅｌａｔｉｏｎｗｉｔｈａｎｇｉｏｇｅｎｅｓｉｓｉｎｃｏｌｏｒｅｃｔａｌｃａｎｃｅ[J]. Chinese Clinical Oncology, 2009, 14(1): 29 .
[8] . [J]. Chinese Clinical Oncology, 2009, 14(1): 70 .
[9] . [J]. Chinese Clinical Oncology, 2009, 14(1): 43 .
[10] . [J]. Chinese Clinical Oncology, 2009, 14(1): 51 .
Copyright © Chinese Clinical Oncology, All Rights Reserved.
Tel: 025-84400143 85862116　E-mail: lczlx@csco.org.cn; lczlx@vip.163.com
Powered by Beijing Magtech Co. Ltd